Treatment for COVID-19: An overview
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
The recent exposure of novel coronavirus strain, severe acute respiratory syndrome (SARS-
CoV-2) has spread to different countries at an alarming rate. Faster transmission rate and …
CoV-2) has spread to different countries at an alarming rate. Faster transmission rate and …
The immune response and effectiveness of COVID-19 therapies
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is highly pathogenic with relatively high mortality …
syndrome coronavirus 2 (SARS-CoV-2) is highly pathogenic with relatively high mortality …
The cytokine storm in COVID-19: the strongest link to morbidity and mortality in the current epidemic
M Basheer, E Saad, N Assy - COVID, 2022 - mdpi.com
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. The clinical
presentations of the SARS-CoV-2 infection are widely variable and treatment strategies for …
presentations of the SARS-CoV-2 infection are widely variable and treatment strategies for …
Immunomodulation and immunotherapeutics of COVID-19
Severe acute respiratory syndrome coronavirus-2 causes coronavirus disease 2019, a
pandemic which was originated from Wuhan city of China. The pandemic has affected …
pandemic which was originated from Wuhan city of China. The pandemic has affected …
Immunosuppressive drugs and COVID-19: a review
TS Schoot, APM Kerckhoffs, LB Hilbrands… - Frontiers in …, 2020 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether …
syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether …
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)
MW McCarthy - Expert Opinion on Pharmacotherapy, 2022 - Taylor & Francis
ABSTRACT Introduction SARS-CoV-2, the virus that causes COVID-19, elicits a variety of
host responses ranging from asymptomatic or mild illness in most people, to severe disease …
host responses ranging from asymptomatic or mild illness in most people, to severe disease …
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19
and the current standard care relies on supportive treatments. Therefore, based on the fast …
and the current standard care relies on supportive treatments. Therefore, based on the fast …
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …
ongoing public health emergency in the world. Sharing structural and behavioral similarities …
[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …
effort is being made to understand the disease pathogenesis and host factors that …